The chemopreventive effect of celecoxib was reported in animal models of diethylnitrosamine-induced HCC, probably through the sustained inhibition of Akt and JNK-c-Jun survival pathways 40, 55, 56. This evidence concerns the gene JUN and hepatocellular carcinoma.